Skip to main content
M
Doctor-Reviewed Content Verified Hospital Data Updated Medical Information Patient-First Guidance Not for Emergencies — Call 911

Laparoscopy Repair of Diaphragmatic Hernia — Cost, Top Hospitals & Success Rates | MyMedicPlus

Updated: 2026-06-26
Ad — after-intro

Quick Facts

Types
Congenital (Bochdalek, Morgagni), traumatic, hiatal/paraesophageal
Congenital C D H Incidence
1 in 2,000–4,000 live births; 20–30% mortality with associated anomalies
E C M O Requirement
25–35% of severe CDH neonates require extracorporeal membrane oxygenation
Paraesophageal Hernia Repair
Elective laparoscopic repair recommended for symptomatic type II–IV hernias
Mesh Augmentation
Recommended for defects >5 cm; BioA and Gore Bio-A meshes widely used
Recurrence Rate
Primary repair 12–25%; mesh repair 5–10% at 5 years (large hernias)
Reviewed By
MyMedicPlus Medical Review Board
Last Reviewed
2026-06-26

Overview of Laparoscopic Diaphragmatic Hernia Repair

Diaphragmatic hernia describes herniation of abdominal organs through a defect in the diaphragm into the thoracic cavity. The condition encompasses a spectrum of disorders from life-threatening congenital defects in neonates to incidentally discovered chronic adult hernias, and the surgical approach varies accordingly. Laparoscopic repair has become the preferred technique across most diaphragmatic hernia subtypes in patients who are haemodynamically stable, offering reduced morbidity, faster recovery, and equivalent or superior durability compared to open thoracotomy or laparotomy.

The diaphragm is the dome-shaped musculotendinous structure separating the thoracic and abdominal cavities, perforated by the aorta, inferior vena cava, and oesophagus through well-defined hiatuses. Failure of embryological closure of pleuroperitoneal folds leads to congenital defects, while trauma, iatrogenic injury, or progressive herniation of stomach through the oesophageal hiatus produces acquired defects.

Classification of Diaphragmatic Hernias

  • Congenital diaphragmatic hernia (CDH): Most commonly the Bochdalek hernia (posterolateral defect, 80–90% of CDH), arising from failure of the pleuroperitoneal membrane to close by week 8 of gestation. The Morgagni hernia (retrosternal anterior defect) is less common (2–5%). CDH allows herniation of intestine, stomach, spleen, or liver into the thorax during fetal development, impairing ipsilateral lung growth and causing pulmonary hypoplasia — the major determinant of mortality.
  • Acquired traumatic diaphragmatic hernia: Results from blunt or penetrating thoracoabdominal trauma (typically motor vehicle collision, stab wounds). Blunt trauma causes large radial tears of the left hemidiaphragm; penetrating trauma causes smaller defects. Diagnosis may be delayed months to years.
  • Hiatal and paraesophageal hernia: Herniation of the gastric cardia and/or fundus through the oesophageal hiatus. Type I (sliding hiatal hernia) is most common; types II–IV (paraesophageal hernias) — where the fundus or entire stomach herniates alongside or above the cardia — carry risk of strangulation and volvulus.

Types of Diaphragmatic Hernia Treated

Laparoscopic repair addresses distinct clinical entities within the diaphragmatic hernia spectrum, each with different patient populations, presenting features, and operative strategies.

Congenital Diaphragmatic Hernia (Bochdalek) in Neonates

Bochdalek CDH — a posterolateral left-sided defect in 75–80% of cases — presents in the neonatal period with respiratory distress, reduced breath sounds on the affected side, a scaphoid abdomen (due to bowel displacement into the thorax), and cyanosis. Antenatal diagnosis (by ultrasound at 18–22 weeks gestation) allows planned delivery at a tertiary centre with neonatal surgical and intensive care expertise.

The herniated viscera (typically small intestine, large bowel, and stomach; occasionally spleen, left lobe of liver) compress the developing lungs, causing bilateral pulmonary hypoplasia — the primary cause of mortality and morbidity in CDH. The degree of lung hypoplasia is assessed by the lung-to-head ratio (LHR) and observed/expected LHR (o/e LHR) on antenatal ultrasound, with an o/e LHR <25% indicating severe disease and very high mortality. Liver herniation (present in 50–60% of left-sided CDH) is an independent predictor of worse outcome.

Management in the neonatal period prioritises stabilisation and ventilatory support before surgery: gentle ventilation (peak inspiratory pressure <25 cmH2O to avoid barotrauma), permissive hypercapnia, inhaled nitric oxide (iNO) for pulmonary hypertension, and high-frequency oscillatory ventilation (HFOV). In 25–35% of severe CDH cases, extracorporeal membrane oxygenation (ECMO) is required as a bridge to pulmonary stabilisation before repair can be undertaken safely.

Paraesophageal and Giant Hiatal Hernia in Adults

Paraesophageal hernias (types II–IV) involve herniation of the gastric fundus, antrum, or entire stomach alongside or above the oesophagogastric junction into the posterior mediastinum. Symptoms include postprandial epigastric pain, dysphagia, early satiety, anaemia (from Cameron ulcers on the mucosal folds), and — in acute cases — gastric volvulus with severe chest pain, retching without vomiting, and inability to pass a nasogastric tube (Borchardt's triad).

Traumatic Diaphragmatic Hernia

Delayed diagnosis of post-traumatic diaphragmatic hernia — frequently overlooked at initial trauma assessment — can present years later with incarceration of bowel, colon, stomach, or spleen. CT with oral contrast provides definitive diagnosis. Early repair before strangulation develops is strongly recommended.

Patient Selection and Pre-Operative Assessment

Eligibility for laparoscopic versus open diaphragmatic hernia repair depends on the type of hernia, patient stability, urgency, and surgical expertise available.

Congenital CDH in Neonates

Neonates with CDH undergo repair only after haemodynamic and ventilatory stabilisation — the principle of 'repair the lungs, not the hernia' guides contemporary management. Surgery is generally deferred until: pulmonary arterial pressures are normalised (oxygenation index <5), the patient has been off iNO for 24 hours, inotrope requirements are low, and lactic acidosis has resolved. Laparoscopic (or thoracoscopic) repair of CDH in neonates is feasible but technically demanding — a small working space, neonatal physiology with carbon dioxide sensitivity, and inability to tolerate prolonged pneumoperitoneum (typically limited to 5–6 mmHg for neonates vs 12–15 mmHg for adults) make this approach suitable only at very high-volume specialist paediatric surgery centres. Open repair via subcostal laparotomy remains the standard at most centres.

Adults with Paraesophageal Hernia

Pre-operative workup for elective laparoscopic paraesophageal hernia repair includes: upper GI endoscopy (to assess oesophagitis, Barrett's oesophagus, and intragastric ulcers/Cameron lesions); CT chest/abdomen to delineate hernia size, herniated organ content, and sac anatomy; barium swallow to define the oesophagogastric junction position and gastric orientation; and high-resolution oesophageal manometry to determine whether a concurrent fundoplication is appropriate and which wrap type to select. Elective repair is recommended for all symptomatic paraesophageal hernias and for large asymptomatic hernias (>50% intrathoracic stomach) given the 1–2% annual risk of acute volvulus. Emergency repair of acute gastric volvulus requires immediate surgical decompression.

Traumatic Diaphragmatic Hernia

Elective laparoscopic repair is appropriate for incidentally discovered or delayed-presentation traumatic hernias in haemodynamically stable patients without evidence of bowel strangulation. Acute traumatic hernias in the polytrauma setting are managed via open thoracotomy or laparotomy depending on the dominant injury.

Surgical Approaches and Repair Techniques

The operative approach and repair strategy for diaphragmatic hernia are tailored to hernia type, defect size, and patient physiology.

Laparoscopic Paraesophageal Hernia Repair

The most common adult laparoscopic diaphragmatic hernia repair follows a standardised sequence: (1) Hernia sac mobilisation and reduction — the peritoneal sac that lines the hernia is identified and dissected free from mediastinal structures, excised where possible (sac excision is associated with lower recurrence than reduction alone), and the herniated stomach is reduced into the abdomen; (2) Oesophageal mobilisation — the oesophagus is mobilised in the posterior mediastinum to achieve a minimum 3–4 cm intraabdominal length without tension; (3) Crural repair — the right and left crural pillars are approximated with interrupted non-absorbable sutures (polypropylene or polyester) placed posteriorly, reducing the enlarged hiatus to admit two fingers alongside the oesophagus; (4) Mesh augmentation if the crural defect is >5 cm or if primary closure is under tension; (5) Addition of a fundoplication (Nissen 360° or Toupet 270°) to anchor the stomach in the abdomen and provide anti-reflux protection.

Primary Repair vs Mesh Augmentation

Primary crural repair without mesh is appropriate for small to medium defects (<5 cm). For large defects (>5 cm) or re-operative cases where primary closure is under tension, mesh augmentation significantly reduces recurrence rates. The PIONEER trial and meta-analyses demonstrate recurrence rates of 5–10% with mesh versus 20–30% with primary suture repair alone for large hernias at 5-year follow-up.

Synthetic polypropylene mesh has fallen out of favour for hiatal augmentation due to reports of oesophageal erosion, fibrotic stricture, and dysphagia. Biological meshes — particularly BioA mesh (Gore Bio-A Tissue Reinforcement, a bioabsorbable polyglycolic acid:trimethylene carbonate composite) and porcine small intestine submucosa (Surgisis) — have demonstrated acceptable recurrence rates with reduced long-term erosion risk in randomised trials. Biologic mesh is placed as an onlay or underlay over the crural repair, not as a tension-free bridging repair.

Thoracoscopic vs Laparoscopic Approach for Congenital CDH

Both thoracoscopic (right or left video-assisted thoracoscopic surgery, VATS) and laparoscopic approaches are described for neonatal CDH repair. Thoracoscopy provides direct access to the defect without requiring bowel reduction before closure; laparoscopy allows better visualisation of bowel adhesions and facilitates complex organ reduction. A systematic review and meta-analysis (Gomes Ferreira et al.) comparing thoracoscopic to open CDH repair found higher recurrence rates with thoracoscopy (10–14% vs 3–5% open) but reduced wound morbidity — suggesting open repair remains the standard in most neonatal centres. In selected stable neonates with small defects at highly specialised centres, thoracoscopic repair achieves good outcomes.

Benefits of Laparoscopic Repair

Laparoscopic diaphragmatic hernia repair offers well-documented advantages over open surgical approaches for adult paraesophageal and traumatic hernias.

Reduced Pulmonary Complications

Avoidance of thoracotomy or large laparotomy significantly reduces post-operative respiratory morbidity — particularly important in elderly patients with paraesophageal hernias who frequently have pre-existing cardiorespiratory disease. Laparoscopic repair avoids the splinting effect of a large chest or abdominal incision, enabling deeper respiration and earlier mobilisation.

Lower Wound Complication Rate

The elimination of a large abdominal wound reduces wound infection, dehiscence, and incisional hernia risk — complications that are particularly prevalent in elderly, obese, or steroid-dependent patients.

Shorter Hospital Stay

Elective laparoscopic paraesophageal hernia repair allows discharge within 1–3 days in uncomplicated cases, compared to 5–7 days after open laparotomy or thoracotomy. Recovery is correspondingly faster, with return to normal activity within 3–4 weeks versus 6–8 weeks after open repair.

Complete Sac Excision and Mediastinal Access

Laparoscopy provides superior visualisation of the posterior mediastinum and enables thorough sac dissection and excision under direct magnified vision — a technically important step in reducing hernia recurrence that is more easily achieved laparoscopically than through a limited open incision.

Simultaneous Anti-Reflux Procedure

Concurrent fundoplication (in 80–95% of laparoscopic paraesophageal hernia repairs) provides anti-reflux protection and anchors the stomach below the diaphragm, addressing the functional component of the disease in addition to the anatomical defect.

Risks and Complications

Laparoscopic diaphragmatic hernia repair carries specific risks that vary significantly between congenital neonatal repair and adult paraesophageal repair.

Recurrence

Hernia recurrence is the most common long-term complication, and rates are higher for larger defects and in the absence of mesh augmentation. Five-year radiological recurrence rates are approximately 5–10% with mesh and 20–30% without mesh for defects larger than 5 cm. Clinical recurrence (symptomatic with need for re-operation) is lower — approximately 5–7%. Risk factors include: large defect size, obesity, persistent postoperative vomiting or straining, inadequate crural approximation, and mesh fixation failure.

Oesophageal Injury

The oesophagus is at risk during mediastinal mobilisation, particularly in re-operative cases with dense adhesions. Inadvertent oesophagotomy, if recognised, is repaired laparoscopically; if unrecognised, it presents as mediastinitis requiring urgent drainage and repair.

Pneumothorax and Pleural Injury

The pleura may be inadvertently opened during mediastinal dissection, creating a capnothorax (CO2 tension pneumothorax under pneumoperitoneum). This manifests as a sudden fall in tidal volume and rise in airway pressure. Management involves angled trocar insertion to evacuate gas; formal chest drain placement is rarely required as CO2 absorbs rapidly postoperatively.

Dysphagia

Post-operative dysphagia occurs in 10–25% of patients after paraesophageal hernia repair with fundoplication, most commonly transient due to wrap oedema. Persistent dysphagia beyond 6–8 weeks warrants endoscopy and barium swallow to assess wrap calibration and exclude herniation. Endoscopic balloon dilatation resolves most cases.

Congenital CDH-Specific Complications

  • Pulmonary hypertension persistence: The major determinant of neonatal mortality; requires iNO, sildenafil, or ECMO.
  • Chronic lung disease: Pulmonary hypoplasia leads to long-term respiratory morbidity, including reactive airways disease, reduced exercise tolerance, and, in severely affected survivors, need for supplemental oxygen or ventilatory support.
  • Gastro-oesophageal reflux: Very common after CDH repair (40–70%), requiring PPI therapy and, in severe cases, anti-reflux surgery.
  • Scoliosis and musculoskeletal sequelae: Associated with chest wall asymmetry from early thoracic surgery and diaphragm patch repair.

Postoperative Care and Long-Term Follow-Up

Follow-up after diaphragmatic hernia repair differs substantially between the neonatal CDH population and adult paraesophageal hernia patients.

Adult Paraesophageal Hernia — Postoperative Care

Patients are maintained on a semi-liquid diet for 4–6 weeks as per fundoplication protocol (if performed concurrently). Anti-emetics are prescribed routinely to prevent retching and vomiting, which risks early wrap herniation. PPI therapy is maintained for 8 weeks. Nasogastric tube is not routinely placed but insertion of a soft Ryle's tube decompresses the stomach if gastroparesis (delayed gastric emptying) develops — manifesting as persistent nausea and abdominal bloating. Early outpatient review at 4–6 weeks assesses dietary progression, symptom control, and body weight. Barium swallow at 6–12 months is recommended by most authorities to exclude radiological recurrence, which may be asymptomatic. Repeat endoscopy is performed annually if Barrett's oesophagus was present pre-operatively.

Congenital CDH — Neonatal and Long-Term Follow-Up

Following CDH repair, neonates remain in the NICU for ventilatory weaning, nutrition optimisation (enteral feeding via nasogastric tube commenced within 24–48 hours of stabilisation), monitoring for pulmonary hypertension rebound, and management of ECMO complications where applicable. Extubation is achieved over days to weeks depending on the severity of pulmonary hypoplasia. Gastro-oesophageal reflux occurs in 40–70% of CDH survivors and requires PPI therapy, and in refractory cases, anti-reflux surgery.

Long-term CDH survivor follow-up is conducted by a multidisciplinary team and includes: pulmonology (chronic lung disease management), gastroenterology (reflux, nutrition), cardiology (pulmonary hypertension surveillance), orthopaedics (scoliosis screening), and neurodevelopment (cognitive and developmental assessment — CDH survivors have higher rates of developmental delay, particularly when ECMO was required). Annual pulmonary function testing is recommended through childhood and adolescence.

Hernia Surveillance

All patients — adult and paediatric — require radiological surveillance for recurrence. CT or MRI at 1, 3, and 5 years is recommended after large defect repair with mesh. Recurrence presenting as intermittent symptoms (postprandial pain, early satiety, dysphagia) warrants investigation with barium swallow and CT before symptoms progress to acute volvulus.

Cost Factors and Global Pricing

The cost of diaphragmatic hernia repair varies enormously between congenital neonatal repair — one of the most resource-intensive neonatal surgical conditions — and elective adult laparoscopic paraesophageal hernia repair.

Congenital CDH Neonatal Repair

Total cost of CDH management is dominated by NICU stay, ECMO (if required), ventilatory support, and prolonged nursing care, rather than the operative procedure itself. In the United States, total CDH management cost (including NICU, ECMO, surgery, and hospitalisation) ranges from USD 100,000 to over USD 500,000 for complex cases requiring prolonged ECMO support. In the UK (NHS), CDH care is fully funded; costs are concentrated in specialist paediatric surgical units at regional centres. In India, congenital CDH at specialist paediatric centres (CMC Vellore, AIIMS Delhi, Narayana Health) costs approximately USD 8,000–25,000 including NICU and surgical care — significantly below Western costs.

Adult Paraesophageal Hernia Repair

  • India: USD 2,500–6,000 (private hospital)
  • Thailand: USD 5,500–10,000
  • Turkey: USD 4,000–8,000
  • United Kingdom (NHS): Free for eligible patients; private sector GBP 7,000–14,000
  • United States: USD 20,000–45,000 (elective laparoscopic repair); emergency repair with ICU admission significantly higher

Mesh Cost

Biological mesh (BioA, Surgisis) adds USD 1,200–3,500 per procedure in material costs compared to synthetic mesh or primary repair, but may reduce long-term cost by decreasing recurrence-related re-operation rates.

Emergency vs Elective Surgery

Elective repair of a symptomatic paraesophageal hernia is substantially less costly than emergency repair of an acute volvulus — which requires ICU admission, parenteral nutrition, potential organ resection for ischaemic bowel or stomach, and prolonged hospitalisation. This provides strong economic justification for elective repair of large asymptomatic paraesophageal hernias before complications develop.

Alternatives and Adjuncts to Laparoscopic Repair

The management of diaphragmatic hernia varies by type and severity, with several alternatives to laparoscopic repair considered in specific clinical scenarios.

Open Laparotomy or Thoracotomy

Open repair via upper midline laparotomy or anterolateral thoracotomy remains indicated for: acute gastric volvulus with strangulation requiring en-bloc stomach or bowel resection, traumatic hemidiaphragm tears in the acute polytrauma setting, large complex recurrent hernias with multiple previous abdominal operations, and congenital CDH in most neonatal centres. Open thoracotomy provides superior access to right-sided posterolateral Bochdalek defects involving the right lobe of the liver. Open repair remains the benchmark against which laparoscopic outcomes are compared.

Thoracoscopic (VATS) Repair for Congenital CDH

Video-assisted thoracoscopic surgery (VATS) for neonatal CDH avoids laparotomy and provides direct access to the diaphragmatic defect. However, systematic reviews demonstrate significantly higher recurrence rates (10–14%) compared to open repair (3–5%), and CO2 tension pneumoperitoneum is poorly tolerated in neonates with pulmonary hypertension (CO2 absorption worsens pulmonary vasoconstriction). VATS repair is currently considered investigational and is performed at very few highly specialised centres with strict patient selection criteria (stable, Boey score 0, small defect, no liver herniation).

Fetal Intervention: Fetoscopic Tracheal Occlusion (FETO)

In severe CDH with o/e LHR <25% and liver herniation, fetoscopic endoluminal tracheal occlusion (FETO) — temporary balloon occlusion of the fetal trachea at 27–29 weeks gestation, stimulating lung growth by trapping pulmonary secretions — is an investigational intervention. The randomised TOTAL trial (2021) demonstrated improved survival in severe left CDH with FETO (40% survival with FETO vs 15% without, p=0.002), representing the first proven prenatal intervention for CDH. FETO is available at a limited number of specialist fetal medicine centres worldwide.

Mesh Selection: Synthetic vs Biological

For large hiatal defects, synthetic mesh (polypropylene, polyester) provides excellent tensile strength but carries a 1–3% risk of oesophageal erosion, fibrotic stricture, and chronic dysphagia over 5–10 years. Biological meshes (BioA, Surgisis, Permacol) are degraded and replaced by host tissue over 6–12 months, reducing long-term erosion risk, with randomised trials (Champion et al.) demonstrating lower 6-month radiological recurrence with Surgisis versus primary repair alone. The choice between synthetic and biologic mesh should be individualised based on defect size, expected recurrence risk, and surgeon preference.

Conservative Management of Asymptomatic Small Hernias

Small asymptomatic type I sliding hiatal hernias and incidentally discovered small Morgagni hernias in elderly patients with significant comorbidities may be managed conservatively with close radiological follow-up, PPIs for acid suppression, and dietary modification. The risk of acute strangulation in small uncomplicated hernias is low (<0.5% per year), and surgical risk may outweigh the benefit of repair in frail elderly patients.

Frequently Asked Questions

A Bochdalek hernia is the most common type of congenital diaphragmatic hernia (CDH), caused by failure of the posterolateral diaphragm to close during fetal development, typically on the left side. This allows abdominal organs — including the small bowel, large bowel, stomach, and sometimes the spleen — to herniate into the chest, compressing the developing lungs and causing pulmonary hypoplasia (underdeveloped lungs). In newborns, this manifests as severe respiratory distress immediately after birth. Treatment begins with stabilisation — gentle ventilation, nitric oxide for pulmonary hypertension, and ECMO (heart-lung bypass) in the 25–35% of severe cases that cannot be stabilised with ventilation alone. Surgery to repair the diaphragm is performed only after the baby is stable, usually through a small abdominal incision. The outlook depends primarily on the degree of lung underdevelopment and ranges from excellent for mild cases to 20–30% mortality in severe cases with liver herniation and very small lungs.
A sliding hiatal hernia (type I) occurs when the gastro-oesophageal junction (the join between the oesophagus and stomach) slides upward through the oesophageal hiatus (opening in the diaphragm) into the chest. This is very common, found in over 90% of patients with GERD, and is treated primarily with acid suppression medications or anti-reflux surgery. A paraesophageal hernia (types II–IV) is more serious: the gastro-oesophageal junction stays in place but the gastric fundus, and in severe cases the entire stomach, herniates alongside or above it into the chest. This can cause chest pain, severe vomiting, iron deficiency anaemia, and — in the acute presentation — gastric volvulus (the stomach twists on itself), which is a surgical emergency. Elective laparoscopic repair is recommended for all symptomatic paraesophageal hernias and for large asymptomatic ones because of the risk of acute volvulus.
Whether mesh is needed depends on the size of the diaphragmatic defect. For small hiatal defects under 5 cm, primary repair — sewing the crural muscles together with strong non-absorbable sutures — is sufficient, with recurrence rates under 10%. For larger defects over 5 cm, primary suture repair alone has high recurrence rates of 20–30% at five years, and mesh augmentation is strongly recommended. Biological meshes (such as Gore BioA or Surgisis, which are absorbed by the body over 6–12 months and replaced by scar tissue) are preferred over permanent synthetic meshes at the hiatus because synthetic mesh can erode into the oesophagus over time. The mesh is placed as an onlay or underlay reinforcement over the sutured crura — it is not used as a tension-free bridge to avoid a stricturing effect on the oesophagus.
Fetoscopic endoluminal tracheal occlusion (FETO) is a minimally invasive fetal procedure for severe congenital diaphragmatic hernia diagnosed before birth. A tiny balloon is inserted through the fetal mouth into the trachea under ultrasound guidance at around 27–29 weeks of pregnancy. By blocking the fetal trachea, pulmonary fluid builds up, stimulating the hypoplastic (underdeveloped) lungs to grow before birth. The balloon is removed at around 34 weeks (or sooner if labour begins). The 2021 TOTAL trial showed FETO improved survival in severe left-sided CDH from 15% to 40%. FETO is offered to pregnancies with an observed-to-expected lung-to-head ratio below 25% and liver herniation — indicating severe disease and very poor prognosis without intervention. It is available at a small number of specialist fetal medicine centres worldwide, including in Belgium, the UK, the US, and Brazil.
CDH survivors have a range of potential long-term health concerns that require multidisciplinary follow-up through childhood. Gastro-oesophageal reflux affects 40–70% of CDH survivors and may require long-term PPI therapy or, in severe cases, anti-reflux surgery. Chronic lung disease — manifesting as exercise intolerance, asthma-like reactive airways disease, and reduced pulmonary function test results — is common, particularly after severe CDH or ECMO. Scoliosis and chest wall asymmetry may develop due to early thoracic surgery. Hernia recurrence can occur in the months to years after initial repair. Approximately 20–30% of CDH survivors — particularly those who required ECMO — have some degree of neurodevelopmental delay, learning difficulties, or hearing impairment. For these reasons, CDH survivors are followed by a multidisciplinary team including respiratory paediatricians, gastroenterologists, orthopaedic surgeons, and developmental paediatricians.

References

  1. Snoek KG, et al. Standardized Postnatal Management of Infants with Congenital Diaphragmatic Hernia in Europe: The CDH EURO Consortium Consensus - 2015 Update. Neonatology. 2016;110(1):66-74.
  2. Deprest JA, et al. Randomized Trial of Fetal Surgery for Severe Left Diaphragmatic Hernia (TOTAL trial). N Engl J Med. 2021;385(2):107-118.
  3. Oelschlager BK, et al. Biologic prosthesis reduces recurrence after laparoscopic paraesophageal hernia repair: a multicenter, prospective, randomized trial. Ann Surg. 2011;253(3):484-490.
  4. Champion JK, et al. Biologic mesh in large hiatal defect repair: a 5-year follow-up study. Surg Endosc. 2017;31(9):3622-3627.
  5. Gomes Ferreira C, et al. Thoracoscopic versus open repair for congenital diaphragmatic hernia: a meta-analysis. J Pediatr Surg. 2021;56(5):848-856.
Ad — after-content

Medically Reviewed

Our medical content follows strict editorial guidelines to ensure accuracy and reliability.

Up to Date

Last updated: 2026-06-26

Important: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.

Ready to take the next step?

Connect with top hospitals and specialists. Get personalized guidance for your medical journey.

Latest from our blog and forum

Latest from Our Blog

View All →

Latest Forum Discussions

View All →
Compare Costs Get Free Help

Medical Disclaimer: The information on MyMedicPlus is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site.